EXPERT OPINION
LIVE

Serial Number

79118677

Owner

Informa UK Limited

Filing Date

Jan 24, 2012

Add to watchlist:

No watchlists yet
View on USPTO

EXPERT OPINION Trademark

Serial Number: 79118677 • Registration: 4499914

EXPERT OPINION is a trademark filed by Informa UK Limited on January 24, 2012. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Informa UK Limited (69 trademarks)

5 Howick Place
London SW1P1WG , GB

Entity Type: 11

Trademark Details

Filing Date

January 24, 2012

Registration Date

March 25, 2014

Published for Opposition

January 7, 2014

Cancellation Date

January 24, 2022

Goods & Services

Education services, namely, providing educational seminars, conferences, classes and workshops in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; providing training in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; entertainment and recreational services, namely, arranging and conducting of sporting and cultural events, training and educational conferences, courses, seminars and exhibitions in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Publishing and issuing of scientific papers in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Electronic publishing services, namely, publication of text and graphic works of others online featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; the provision of news online in the nature of news agencies, namely, gathering and dissemination of news; the provision of online, nondownloadable publications in the nature of journals, articles, magazines, bulletins and newspapers featuring information in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare disseminated via the Internet; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the Internet

Apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, prerecorded magnetic data carriers featuring information and data in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; blank recording optical discs; pre-recorded CDs, video tapes, laser disks and DVDs featuring information in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare and manuals in electronic format sold as a unit; computer software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable electronic publications in the nature of journals, articles, magazines, bulletins and newspapers featuring information in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare provided on-line from databases or the internet; computer programs featuring programming languages in electronic form for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; prerecorded magnetic, electronic or optical data carriers featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; electronic publications, namely, instruction manuals in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare recorded on computer media all recorded magnetically, optically or electronically

Paper, cardboard and goods made from these materials, not included in other classes, namely, boxes, cartons, storage containers, and packaging containers; printed matter, namely, journals, newsletters, reports, and directories featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; printed matter, namely, reports, journals, articles, magazines, books, newspapers, news bulletins, newsletters and brochures relating to computer software and programmes; book-binding material; photographs; stationery; instructional and teaching materials other than apparatus, namely, journals, articles, newsletters and seminar notes in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare

Medical services; advisory medical services and the provision of medical information; dentistry services; advisory services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; medical consultation in the field of health risk assessment, namely, prediction and assessment of health risks to public and private agencies, facilities, individuals and locations following the administration of chemical, biological radiological or nuclear materials; pharmaceutical advisory services; the provision of information relating to pharmaceuticals; dispensing of pharmaceuticals; veterinary services; preparation of medical reports; issuing of medical reports; advisory services and the provision of information relating to surgery, including cosmetic surgery; advisory services and the provision of information relating to cosmetic treatment in the nature of cosmetic and plastic surgery, cosmetic skin care services, cosmetic peels; hygienic and beauty care for human beings or animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the Internet

Industrial analysis and research services, namely, medical research; provision of information, including the online provision of such information, relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services; design and development of computer hardware and software; design and development of computer software, being software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; design and development of computer software, being software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; technical consultancy and advisory services in the field of computer hardware and software; consultancy, design, testing, research and advisory services, all relating to computing and computer programming; website design services; computer programming; computer systems analysis; computer timesharing; research and development of computer hardware and software; technological services relating to computers; rental and leasing of computers; computer programming; computer rental and updating of computer software; computer software design; hosting of websites; hosting of digital content in the nature of online journals and blogs; technical consultancy and advisory services in the field of computer networks; technical support services, namely, troubleshooting of computer software problems via computer help-lines; technical support services, namely, troubleshooting relating to computer hardware, computer software, computer networks and the Internet; hosting on-line web facilities for the search, retrieval, indexing and organization of data on electronic communication networks and for enhancing the performance and function of such networks; database design and development; information, consultancy and advisory services relating to all the aforesaid services including such services provided on-line or via the Internet

Filing History

UNDELIVERABLE MAIL - NO ACTION TAKEN
Nov 17, 2022 UNDN
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Aug 21, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Aug 21, 2022 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Dec 12, 2021 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 17, 2021 INTS
INVALIDATION PROCESSED
Nov 17, 2021 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CANCELLED SECTION 71
Feb 26, 2021 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
Oct 8, 2015 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 12, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 26, 2014 FICS
FINAL DISPOSITION PROCESSED
Jun 26, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 25, 2014 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 3, 2014 OPNX
REGISTERED-PRINCIPAL REGISTER
Mar 25, 2014 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 19, 2014 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 19, 2014 OPNR
PUBLISHED FOR OPPOSITION
Jan 7, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Jan 5, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2013 OP2R
NOTICE OF PUBLICATION
Dec 18, 2013 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 5, 2013 PREV
ASSIGNED TO LIE
Dec 5, 2013 ALIE
EXAMINERS AMENDMENT MAILED
Nov 12, 2013 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 12, 2013 XAEC
EXAMINERS AMENDMENT -WRITTEN
Nov 12, 2013 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 8, 2013 TROA
NON-FINAL ACTION MAILED
May 9, 2013 CNRT
NON-FINAL ACTION WRITTEN
May 9, 2013 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2013 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Apr 5, 2013 NREP
REFUSAL PROCESSED BY IB
Nov 19, 2012 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 1, 2012 RFCS
REFUSAL PROCESSED BY MPU
Nov 1, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 1, 2012 RFCR
NON-FINAL ACTION WRITTEN
Oct 31, 2012 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 30, 2012 MAFR
ASSIGNED TO EXAMINER
Oct 24, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 23, 2012 REPR